Evolving role of chemotherapy in resected liver metastases

Journal of Clinical Oncology

Volumn 24, Issue 31, 2006, Pages 4952-4953

  Alberts, Steven R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLOXURIDINE; FLUOROURACIL; IRINOTECAN; OXALIPLATIN; ANTINEOPLASTIC AGENT;

CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EDITORIAL; HUMAN; LIVER METASTASIS; LIVER SURGERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ADJUVANT CHEMOTHERAPY; COLORECTAL TUMOR; LIVER RESECTION; LIVER TUMOR; METASTASIS; MULTICENTER STUDY; NOTE; PATHOLOGY; TUMOR RECURRENCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MULTICENTER STUDIES; NEOPLASM RECURRENCE, LOCAL; RANDOMIZED CONTROLLED TRIALS;

EID: 33750961848     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.07.9236     Document Type: Editorial

References (12)

1. Woodington GF, Waugh JM: Results of resection of metastatic tumors of the liver. Am J Surg 105:24-29, 1963
2. Silen W: Hepatic resection for metastases from colorectal carcinoma is of dubious value. Arch Surg 124:1021-1022, 1989
3. Belli G, D'Agostino A, Ciciliano F, et al: Liver resection for hepatic metastases: 15 years of experience. J Hepatobiliary Pancreat Surg 9:607-613, 2002
4. Fong Y, Fortner J, Sun RL, et al: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 230:309-318, 1999; discussion 318-321, 1999
5. Nordlinger B, Guiguet M, Vaillant JC, et al: Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie Cancer 77:1254-1262, 1996
6. Hughes KS, Rosenstein RB, Songhorabodi S, et al: Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of long-term survivors. Dis Colon Rectum 31:1-4, 1988
7. Scheele J, Altendorf-Hofmann A: Resection of colorectal liver metastases. Langenbeck's Arch Surg 384:313-327, 1999
8. Fong Y, Cohen AM, Former JG, et al: Liver resection for colorectal metastases. J Clin Oncol 15:938-946, 1997
9. Lorenz M, Muller HH, Schramm H, et al: Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer: German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 228:756-762, 1998
10. Kemeny MM, Adak S, Gray B, et al: Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - an Intergroup study. J Clin Oncol 20:1499-1505, 2002
11. Portier G, Elias D, Bouche O, et al: Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 24: 4976-4982, 2006
12. Kemeny N, Huang Y, Cohen AM, et al: Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341:2039-2048, 1999